Eversept Partners, LP Pliant Therapeutics, Inc. Transaction History

Eversept Partners, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Nov 08, 2023	SELL	$17.0 - $25.43 $2.66 Million - $3.98 Million	-156,680 Reduced 53.27%	137,423 $2.66 Million
Q4 2022 Feb 14, 2023	SELL	$17.0 - $25.43 $2.66 Million - $3.98 Million	-156,680 Reduced 53.27%	137,423 $2.66 Million
Q3 2022 Nov 08, 2023	BUY	$7.67 - $24.23 $2.26 Million - $7.13 Million	294,103 New	294,103 $6.14 Million
Q3 2022 Nov 14, 2022	BUY	$7.67 - $24.23 $2.26 Million - $7.13 Million	294,103 New	294,103 $6.14 Million

168

63.2M

245K

373K

Ticker PLRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,682,000
Market Cap $600M
Description
Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...

Get notified when there are updates to the investment portfolio of Eversept Partners, LP, based on Form 13F filings with the SEC.

Stay updated on Eversept Partners, LP with notifications on news.